2018/10/18 17:10:23
1298
| 102年 | ||||
| I. SCI期刊論文 | ||||
| 編號 |
題目（畫線者為通訊作者）
|
SCI IF/ Rank | ||
| 1 | Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. BIOMARKERS,18(1):44-50, 2013. #新陳代謝科、心臟內科：：#許惠恒，梁凱偉，廖英傑，李文珍，李文領，李奕德，王俊興，丁紀台。 |
2.215 (論文) (74/158) |
||
| 2 | Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obesity Research & Clinical Practice,2013(7):e81-e88,2013. #新陳代謝科、營養室：：#許惠恒，周靜雅，郎惠芬。 |
0.324 (論文) (117/122) |
||
| 3 | xenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. LANCET,381(1):117-124,2013. #新陳代謝科：：#許惠恒， Michael Thomas Sylvia Cory R 等11人。 |
38.278 |
||
| 4 | Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study JOURNAL OF INTERNAL MEDICINE,273(1):102-110, 2013. #研究部、新陳代謝：：#許惠恒，林敬恒。 |
5.483 (論文) (12/155) |
||
| 5 | Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,112卷,1冊,144-150頁, 2013年. #新陳代謝科：：#盧介祥，莊立民。 |
1.132 |
||
| 6 | Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men CLINICA CHIMICA ACTA,421卷,1冊,98-103頁, 2013年 #新陳代謝科：：#林時逸，傅家保，許惠恒，李奕德，蔡依橙，李文珍，梁凱偉，李文領。 |
2.535 (論文) (6/32) |
||
| 7 | Trans-Ethnic Fine-Mapping of Lipid Loci Identifies Population-Specific Signals and Allelic Heterogeneity That Increases the Trait Variance Explained. PLoS Genetics,9卷,3冊,1-16頁, 2013年. #新陳代謝科：：#Ying Wu，L L.W，A U.J，許惠恒，李文珍，李奕德，K L.W |
8.694 (論文) |
||
| 8 | Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan .IABETES RESEARCH AND CLINICAL PRACTICE,99卷,1冊,112-119頁, 2013年 #新陳代謝科：：#游能俊，許惠恒，H-Y S，S-T C，M-C Y，S-W Y，M-S T |
2.754 (論文) (56/122) |
||
| 9 | Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation. Journal of Pathology 2013; 230: 215–227. #新陳代謝科、研究部：#許惠恒，劉興華，李茂榮，李文珍，易瑜嶠，楊宗杰，鄭政峰，潘宏川，沈錦昌，陳文寶，田幸茹。 |
4.092 (論文) (12/85) |
||
| 10 | Hyperglycemia Accelerates ATP-Binding Cassette Transporter A1 Degradation Via an ERK-Dependent Pathway in Macrophages. JOURNAL OF CELLULAR BIOCHEMISTRY,114卷,1冊,1364-73頁, 2013年. #新陳代謝科：#張育誠，姜安娜，許惠恒，Y-S C，P-C T，李文珍。 |
2.868 (論文) (142/290) |
||
| 11 | High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. JOURNAL OF DIABETES AND ITS COMPLICATIONS,27卷,3冊,243-7頁, 2013年. #新陳代謝科：#李奕德，許惠恒，C-Y W，C-N H，C-C F |
2.032 (論文) (80/122) |
||
| 12 | Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. BIOMARKERS,18(1):44-50, 2013. #心臟內科、新陳代謝科：#梁凱偉，廖英傑，許惠恒，李文珍，李文領，李奕德，王俊興，丁紀台。 |
2.215 (論文) (74/158) |
||
| 13 | Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obesity Research & Clinical Practice,2013(7):e81-e88, 2013. #營養室、新陳代謝科：#許惠恒，郎惠芬。 |
0.324 (論文) (117/122) |
||
|
II.非SCI期刊論文
|
||||
| 1 | 低血糖與認知功能障礙：當代醫學,40卷,1冊,7-9頁, 2013年. #新陳代謝科：#許惠恒， |
102N1 NSCI |
||
| 101年 | ||||
| I. SCI期刊論文 | ||||
| 編號 |
題目（畫線者為通訊作者）
|
SCI IF/ Rank
|
||
| 1 |
Managing diabetes in Asia:Overcoming obstacles and the role of DPP-IV inhibitors. |
2.134 (論文) (80/116) |
||
| 2 | Low estimated glomerular filtration rate is a major determinant of low ankle-brachial indexa and toe-brachial index in type 2 diabetes. ANGIOLOGY #新陳代謝科：#沈宜靜，許惠恆，林建良，李奕德，YN Hsu，TC Li。 |
0.992 (論文) (56/68) |
||
| 3 | Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. CLINICAL ENDOCRINOLOGY #新陳代謝科：#YF Chiu等4人許惠恒:5李文珍:8等10人。 |
3.323 (論文) (44/116) |
||
| 4 | Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome.NUTRITION RESEARCH #新陳代謝科：#李奕德，許惠恒，李文珍，蔡敬民，蘇益仁，顏賢棟。 |
2.092 (論文) (37/70) |
||
| 5 | Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. CLINICA CHIMICA ACTA #新陳代謝科：#李奕德，許惠恒，李文珍，蔡依橙，梁凱偉，林時逸，萬居仁，傅家保。 |
2.389 (論文) (6/31) |
||
| 6 | Diabetes-specific nutrition algorithm: A transcultural program to optimize diabetes and prediabetes care. Current Diabetes Reports #新陳代謝科：#Jeffrey IM，許惠恒:11 等14人 |
2.210 (論文) (14/116) |
||
| 7 | Transculturalization of a diabetes-specific nutrition algorithm: asian application . Current Diabetes Reports #新陳代謝科：#蘇秀悅，許惠恒，M-W T，黃士懿，S-Y H，J.I. M |
2.210 |
||
| 8 | Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling. JOURNAL OF VASCULAR SURGERY #新陳代謝科：#歐秀中，許惠恒，李文珍，C-M Wu，JF-M C |
3.853 |
||
| 9 | Docosahexaenoic acid attenuates VCAM-1 expression and NF-kB activation in TNF-a-treated human aortic endothelial cells. JOURNAL OF NUTRITIONAL BIOCHEMISTRY #新陳代謝科：#Tzu-Ming Wang，姜安娜，C-J C，T-S L，W-H W，S-C H，許惠恒 |
4.538 (論文) (5/70) |
||
| 10 | Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemia agents in the Asia-Pacific region . DIABETES RESEARCH AND CLINICAL PRACTICE #新陳代謝科：#許惠恒，Siew-Pheng Chan，L-NJi 等6人 |
2.134 (論文) (80/116) |
||
| 11 | Addressing self-monitoring of blood glucose: Advocating paired glycemic testing for people with type 2 diabetes. Journal of Diabetes Investigation 有引述3篇作者論著 #新陳代謝科：#許惠恒 |
1.861 (論文) (86/121) |
||
| 12 | Links among type 2 diabetes, cancer and metformin use: What have we learned? DIABETES RESEARCH AND CLINICAL PRACTICE有引述3篇作者論著 #新陳代謝科：#Yi Jing Sheen，許惠恒 |
2.134 (論文) (80/116) |
||
| 13 | Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) Taiwan follow-up study. Cardiovascular Diabetology #新陳代謝科：#李奕德，許惠恒，邱燕芳，胡啓名，C-T He，江福田，Y-C L，Assimes，J D Curb |
2.72 (論文) (43/114) |
||
| 14 | The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men. CLINICA CHIMICA ACTA #新陳代謝科：#傅家保，林時逸，李奕德，許惠恒，李文珍，梁凱偉，李文領 |
2.389 (論文) (6/31) |
||
| 15 | Anti-atherogenic effects of resveratrol via liver x receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages. Journal of Functional Foods #新陳代謝科：#張純毓，許惠恒，李宗翰 |
1.308 (論文) (49/128) |
||
| 16 | Comparison of the Efficacy and Safety Profiles of Two Fixed-Dose Combinations of Antihypertensive Agents, Amlodipine/Benazepril Versus Valsartan/Hydrochlorothiazide, in Patients With Type 2 Diabetes Mellitus and Hypertension: A 16-Week, Multicenter, Randomized, Double-Blind, Noninferiority Study. CLINICAL THERAPEUTICS #新陳代謝科：#李奕德，許惠恒，洪乙仁，陳榮福 ，王治元 ，李文珍 |
2.551 (論文) (108/252) |
||
|
II.非SCI期刊論文
|
||||
| 1 | 血管張力素受體阻斷劑(ARB)早期預防糖尿病腎病變：ROADMAP研究之啟示. 當代醫學 #新陳代謝科：#許承嵐，許惠恒 |
101N22 NSCI |
||
| 2 | A two-year follow up of glycated hemoglobin in a group of oral anti-diabetic or insulin users in a medical center in central Taiwan Formosan Journal of Endocrinology and Metabolism #新陳代謝科：#李佳霖，許惠恒，王俊興，林時逸，李奕德，曾立年，宋育民 |
101N23 NSCI |
||
| 100年 | ||||
| I. SCI期刊論文 | ||||
| 編號 |
題目（畫線者為通訊作者）
|
SCI IF/ Rank
|
||
| 1 | Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring. DIABETES-METABOLISM RESEARCH AND REVIEWS 2011; 27, 1:79-84 IRB認證許可書編號：MCCD060191A/C06211 研究計畫編號：TCVGH-983001C, VGHUST98-G2-1,NSC98-2314-B075A-002-MY3 #新陳代謝科：#王俊興，杜思德，李奕德，林世鐸，林時逸，蘇矢立， 李文珍，許惠恒* |
2.7621 |
||
| 2 | Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 2011; 54, 4:759-764 研究計畫編號：TCVGH-NCHU-977610 #新陳代謝科：#許惠恒，莊琇珺，鄭秀敏，李茂榮，趙琪琪，陳甫州* |
2.4531 |
||
| 3 | Docosahexaenoic acid attenuates VCAM-1 expression and NF-kB activation in TNF-a-treated human aortic endothelial cells. JOURNAL OF NUTRITIONAL BIOCHEMISTRY 2011; 22 :187-194 #新陳代謝科：Tzu-Ming Wang，陳春榮，T-S L，H-Y C，W-H W，S-C H，#許惠恒，姜安娜* |
4.288 (論文) (7/66) |
||
| 4 | Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach - a DEMAND II Study. Journal of the Chinese Medical Association，中華醫誌 2011; 74 :3-10 #新陳代謝科：江淑媛，J-K L，C-H C，莊立民，K-W T，#許惠恒，吳達仁，何橈通* |
0.7 (論文) (83/107) |
||
| 5 | Ellagic acid inhibits oxidized low-density lipoprotein(OxLDL)-induced metalloproteinase (MMP)expression by modulating the protein kinase C-a/extracellular singal-regulated kinase/peroxisome proliferator-activated receptro r/nuclear factor-kB(PKC-a/ERK/PPAR-r/NF-kB) signaling pathway in endothelial cells. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2011; 59 :5100-5108 研究計畫編號：TCVGH-996201,NSC-982320-B-039-020-MT3 #新陳代謝科：M-Y Kuo，歐秀中(並列第一作者)，李文珍，蔡秋聲等，#許惠恒* |
2.469 (論文) (2/45) |
||
| 6 | Addressing the burden of type 2 diabaetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations.DIABETES RESEARCH AND CLINICAL PRACTICE 2011; 92 :312-321 #新陳代謝科：#許惠恒*，Azhari 等 |
2.16 |
||
| 7 | Spirulina prevents memory dysfunction, reduces oxidative stress damage and augments antioxidant activity in senescence-accelerated mice. J Nutr Sci Vitaminol 2011; 57 :186-191 #新陳代謝科：黃知偉，#李奕德，鄭啟清，王銘富，侯建維，吳SM，詹吟菁* |
0.929 (論文) (53/66) |
||
| 8 | The beneficial effect of αglucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: pliminary data. JOURNAL OF DIABETES AND ITS COMPLICATIONS 2011; 25, 5:332-338 IRB認證許可書編號：C06211 研究計畫編號：TCVGH-99G201,NSC 98-2314-B075A-020- MY3 #新陳代謝科：林世鐸，#王俊興，許上人，#許惠恒，#李奕德，#林時逸等，謝明家* |
2.11 (論文) (69/105) |
||
| 9 | Diabetic dyslipidaemia in asian populations in the western pacific region: What we know and don't know. DIABETES RESEARCH AND CLINICAL PRACTICE 2011; 94 :1-13 #新陳代謝科：uliana CN Chan*，#許惠恒，S- P C等 |
2.16 (綜合評論) (66/105) |
||
| 10 | Effects of acarbose versus glibenclamide on glycemic exvursiona nd oxidative stress in type 2 diabetic patients inadequately controlled by metformin: A 24-week, randomized, open-label, parallel-group comparison.CLINICAL THERAPEUTICS 2011; 33, 12:1932-1942 IRB認證許可書編號：C06211 研究計畫編號：TCVGH- 99G201 #新陳代謝科：#王俊興，李文珍，李奕德，林時逸，許惠恒* |
3.25 (論文) (65/237) |
||
| 11 | From casual blood pressure measurement to long-term blood pressure burden: better elucidation of the association between versatile blood pressures and cardiovascular events. HYPERTENSION RESEARCH 2011; 34 :49-51 #新陳代謝科：王宗道，#許惠恒* |
2.426 (綜合評論) (26/61) |
||
|
II.非SCI期刊論文
|
||||
| 1 | Alteration of insulin sensitivity by sex hormones during the menstrual cycle. Journal of Diabetes Investigation ,52卷,2冊,258-259頁, 2011 #新陳代謝科：#許惠恒，許惠恒* |
100N3 綜合評論 |
||
| 2 | Metabolic syndrome and renal injury.Cardiology research and practice 2011; 1-13 #新陳代謝科：沈宜靜，#許惠恒* |
100N5 綜合評論 |
||
| 3 | 糖尿病與癌症之關聯以及台灣現況探討 內科學誌 2011; 22, 1:19-30 #新陳代謝科：沈宜靜，林建良，#許惠恒，沈宜靜* |
100N6 綜合評論 |
||
| 4 | Statin’s Effect on New Incident Diabetes and Blood Glucose Control 史塔丁對新生糖尿病與血糖控制之影響 Journal of Internal Medicine of Taiwan 2011; 22, 2:106-114 #新陳代謝科：#陳拓邦，林時逸，許惠恒* |
100N13 綜合評論 |
||
| 5 | 餐後血糖控制在糖尿病之重要性 當代醫學 2011; 38, 11:858-860 #新陳代謝科：許承儒，#許惠恒* |
100N30 綜合評論 |
||
| 6 | 減重手術緩解第二型糖尿病 當代醫學 2011; 38, 10:744-747 #新陳代謝科：許承嵐，#許惠恒* |
100N31 綜合評論 |
||
| 7 | Primary hypoparathyroidism with an initial presentation of carpal tunnel syndrome: a case report. Formosa J Endocrin Metab 2011; 2 :44-48 #新陳代謝科：#傅家保，王俊興，許惠恒，林時逸* |
100N37 病例報告 |
||
| 8 | 「代謝記憶」在糖尿病相關併發症可能機制探討 內科學誌(Journal of Internal Medicine of Taiwan) 2011; 22, 5:314-323 #新陳代謝科：#蔡婉妮，林時逸，許恵恒* |
100N59 綜合評論 |
||
| 9 | Acute suppurative thyroiditis as invasive Klebsiella Pneumoniae syndrome. Formosan Journal of Endocrinology and Metabolism 2011; 2, 4:89-96 #新陳代謝科：蔡易婷，林時逸，許惠恒，#曾立年* |
100N74 病例報告 |
||
| 99年 | ||||
| I. SCI期刊論文 | ||||
| 編號 |
題目（畫線者為通訊作者）
|
SCI IF/ Rank
|
||
| 1 |
Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway.Toxicology and Applied Pharmacology 248; 134-143, 2010.
＊新陳代謝科：歐秀中（院外人士），李文珍（研究部），＊李奕德，Chih-Yang Huang，Tsan-Hung Chiu，Kun-Ling Tsai， Wen-Cheng Hsu，＊許惠恒。 |
3.364
（論文）
（11/75）
|
||
| 2 |
Genetic variants of human urea transporter-2 are associated with metabolic syndrome in Asian population.
Clinica Chimica ACTA 411:2009-2013, 2010.
新陳代謝科、＊院外人士：＊蔡慧如，＊蕭金福，＊何橈通，＊莊立民，＊Chih-TsuengHe，
＊J.David Curb，＊Thomas Quertermos，＊Chao A. Hsiung，＊熊召，
許惠恒（內科部主任）。 |
2.960
（論文）
（5/27）
|
||
| 3 |
通過IRB認證，許可書編號：C06249
研究計畫編號：TCVGH-963504C
＊林時逸(新陳代謝科主治醫師)，黃詩璇 (院外醫師)，許惠恒(內科部主任醫師) |
2.920
（論文）
（44/93）
|
||
| 4 |
Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia.
Journal of Evaluation in Clinical Practice 2010;16:202–205.通過IRB認證，許可書編號：940213/455
研究計畫編號：TCVGH-NCNU-947901
新陳代謝科，#教研部：*李奕德 (主治醫師)，廖翊儒(院外人士)，#李文珍，
黃建寧(院外人士)，*許惠恒 (內科部主任) |
1.843
（致編者信）
（44/107）
|
||
| 5 |
Metabolic syndrome exacerbating ankle-brachial index in Asian type 2 diabetic patients.
Angiology. 2010 Jul;61(5):482-486 通過IRB認證，許可書編號：C06062 研究計畫編號：TCVGH-973501A
新陳代謝科，#教研部：*李奕德 (主治醫師)，#李文珍，*許惠恒 (內科部主任) |
1.122
（論文）
（47/56）
|
||
| 6 |
Glucose exacerbates zinc-induced astrocyte death Toxicology Letters 199 (2010) 102-109
通過動物實驗管理小組審查，同意書編號：La-95245 引用研究計畫編號：TCVGH-T957803, TCVGH-HK958005
泌尿外科、☆院外人士、＊研究部：☆張正一，歐宴泉(泌尿外科主治醫師並列第一作者)，☆高宗桂，潘宏川(神經外科)，林時逸(新陳代謝科)，＊廖素蘭(技術員)，☆王文綺，☆盧錫祺，＊陳春榮(研究員)。 |
3.249
（論文）
（15/75）
|
||
| 7 |
肥胖與糖尿病高血糖會伴隨B型肝炎病人血中肝功能異常增加 Metabolism. 2010 Apr;59(4):486-491.
通過IRB認證，許可書編號：C06246 研究計畫編號：TCVGH-965703C
☆家庭醫學科、＊新陳代謝科：☆王雅瑜 (主治醫師)，＊林時逸 (主治醫師)，許惠恒(內科部主任)，☆劉丕華 (科主任)，董光中 (中興大學獸醫系)。 |
2.920
（論文）
（44/93）
|
||
| 8 |
Protein nitration is associated with increased proteolysis in skeletal muscle of bile duct ligation-induced cirrhotic rats. 總膽管結紮誘發肝硬化鼠之肌肉蛋白氮化會伴隨肌肉蛋白分解增加
Metabolism. 2010 Apr;59(4):468-472. 通過動物實驗管理小組審查，同意書編號：La93154
☆家庭醫學科、＊新陳代謝科：☆王雅瑜(主治醫師)，＊林時逸 (主治醫師)，＊莊玉涵 ，
毛嘉洪(中興大學獸醫系)，董光中(中興大學獸醫系)，許惠恒(內科部主任)。 |
2.920
（論文）
（44/93）
|
||
|
II.非SCI期刊論文
|
||||
| 1 |
Reversible dilated cardiomyopathy in thyrotoxicosis- A case report Formosan Journal of Endocrinology and Metabolism（台灣內分泌暨糖尿病學會雜誌）Formos J Endocrin Metab 2010;2:26-30.
*新陳代謝科：*盧英立（總醫師），林時逸（科主任），許惠恒。 |
病例報告
99N23
|
||
| 2 |
A case of aldosterone-Producing adrenocortical adenoma complicated with a post-operative adrenal glucocorticoid insufficiency. Formosan Journal of Endocrinology and Metabolism（台灣內分泌暨糖尿病學會雜誌）Formos J Endocrin Metab 2010;2:12-16.
*新陳代謝科：*張寶文（院外代訓醫師），宋育民（主治醫師），林時逸，許惠恒 |
病例報告
99N24
|
||
| 3 |
Preliminary clinical application of standard ward-based procedures for preventing hospital hypoglycemia in the general internal medicine ward Formosan Journal of Endocrinology and Metabolism（台灣內分泌暨糖尿病學會雜誌）Formos J Endocrin Metab 2010;2:5-11.
*新陳代謝科：*賴韻如（總醫師），許惠恒（內科部主任），*林時逸（科主任），
廖翊儒（院外人士），劉秀珍，*李奕德（主治醫師） |
論文
99N25
|
||
| 4 |
Clinical suggestions of paired testing of blood glucose for the patients with type 2 diabetes mellitus.
Journal of internal medicine of Taiwan 21, No 5:330-336, 2010.
新陳代謝科：陳柏勳（住院醫師），許惠恒內科部主任）。（ |
論文
99N53
|
||
| 5 |
New advances of management for dyslipidemia in subjects with type 2 diabetes mellitus.
Journal of internal medicine of Taiwan 21, No 5: 322-329, 2010.
新陳代謝科：傅家保（住院醫師），林時逸（科主任），許惠恒內科部主任）。（ |
論文
99N54
|
||
| 98年 | ||||
|
I. SCI期刊論文
|
||||
| 編號 |
題目（畫線者為通訊作者）
|
SCI IF/ Rank
|
||
| 1 |
Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.Clinica Chimica Acta 2009;405:114-118通過IRB認證許可書編號：C08105Yen Tjing Ling Medical Foundation, Taiwan (CI-96-17), TCVGH-973109C, 973102B, National Science, Taiwan (NSC-95-2314-B075A-020-MY3)
心臟內科*、教研部@、新陳代謝科#：梁凱偉*(主治醫師)，李文珍@(研究員)，
李文領*(主治醫師)，丁紀台*(科主任)，許惠恒#(內科部主任)。 |
2.601論文4/26）
|
||
| 2 |
ABC control of diabetes: Survey data from national diabetes health promotion centers in Taiwan
Diabetes research and clinical practice 84:194-200, 2009.VGHTC-983001C
游能俊（院外人士），蘇秀悅，蔡世澤，林瑞祥，徐瑞祥，謝玉娟（以上皆非本院），＊許惠恒（新陳代謝科主治醫師、內科部主任）。 |
1.823
論文
（69/92）
|
||
| 3 |
Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of
endothelium by monocytes in subjects with hypercholesterolemia.Metabolism Clinical and Experimental 58 (2009) 416–420通過IRB認證許可書編號： 910913
*李奕德 (新陳代謝科)，李文珍（教研部），歐秀中，黃建寧，*許惠恒（部主任）。 |
2.647
論文
（43/92）
|
||
| 4 |
Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells.
J Appl Physiol 106:1674-1685, 2009.TCVGH-973001C
＊新陳代謝科：歐秀中（院外人士），李文珍（研究部），＊李奕德，＊林時逸，
＊許惠恒（新陳代謝科主治醫師、內科部主任）。 |
3.632
論文
（2/72）
|
||
| 5 |
Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
Obesity Vol 17, No. 5, P934-935, May 2009.
＊新陳代謝科：**許惠恒(部主任)，吳靜玫(助理)，＊李奕德，李文珍(研究部)。 |
4.953
（致編者信）
（4/56）
|
||
| 6 |
Relation of Adiponectin and High-Sensitivity C-Reactive Protein to Pulse-Wave Velocity and N-Terminal Pro-B-Type Natriuretic Peptide in the General Population Am J Cardiol 103:1411-1416,2009.通過北榮IRB認證
第一作者：Shih-Hsien Sung（院外人士），通訊作者：陳震寰（院外人士），
共同作者：許惠恒(新陳代謝科)，李文珍(研究部)。 |
3.603
論文
（14/75）
|
||
| 7 |
Graves Disease After Thyroid Hormone Treatment for Thyroid Nodule
The Endocrinologist 2009;19: 62-63
*新陳代謝科：*賴韻如(總醫師)，*林時逸，*許惠恒，*李奕德 (主治醫師)。 |
0.164
（病例報告）
（91/92）
|
||
| 8 |
Use of therapeutic responses to glucose replacement to predict glucose patterns in diabetic patients presenting with severe hypoglycaemia. Int J Clin Pract 63, 8: 1161-1166, 2009.
第一作者：Y,-Y,Lin(三總)，許金旺(三總)，許惠恒（新陳代謝科醫師、內科部主任），S-J Chu (三總)，吳清平(三總)，通訊作者：蔡適鴻(三總)。 |
1.594
論文
（39/100）
|
||
| 9 |
Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients. J Eval Clin Pract. 2009 Aug;15(4):699-703.通過IRB認證：940415/552。 引用研究計畫編號：TCVGH-953503A。
*新陳代謝科：*李奕德 (主治醫師)，劉秀珍，廖翊儒(院外人士)，李文珍（研究部）
，黃建寧(院外人士)，*許惠恒 (內科部主任)。 |
1.570
論文
（24/57）
|
||
| 10 | Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal. *林時逸(科主任)，*許惠恒，*宋育民，林延洪(院外人士)，#吳城中，##張文道。 Huang SC, Wu VC, Lin SY, Sheu WH, Song YM, Lin YH, Wu CC, Chang WD. Thyroid. 2009 Jan;19(1):13-20. |
2.692
論文
（42/92）
|
||
| 11 | Effects of patient volume on quality of outpatient diabetes care.Diabetes Res Clin Pract. 2009 May;84(2):e27-9
TCVGH-963505D, 965704D, 963002D.
*新陳代謝科：*王俊興(總醫師)，*林時逸(科主任)，*許惠恒，*李奕德，*曾立年，
*宋育民。 |
1.823
（簡報型論文）
（69/92）
|
||
| 12 |
Effect of melatonin administration on plasma leptin concentration and adipose tissue leptin secrtion in mice.
Acta Biol Hung 2009 Dec;60(4):399-407.
新陳代謝科：宋育民(主治醫師)，陳明德(僑光科技大學通識中心副教授)。 |
0.447
論文
（58/71）
|
||
| 13 |
The effect of calcium channel blocker benidipine and calmodulin antagonist W7 on GDP-binding capacity of brown adipose tissue in mice.Biol Trace Elem Res 2009 127:245-250.
新陳代謝科：宋育民(主治醫師)，陳明德(僑光科技大學通識中心副教授)。 |
0.950
論文
（234/263）
|
||
| 14 |
Visfatin-induced expression of inflammatory mediators in human endothelial cells via the NF-kB pathway.
International Journal of Obesity 33:465-472, 2009通過IRB認證許可書編號：950321/C05200
TCVGH-963001C，TCVGH-967308B，TCVGH-OCIT968409，NSC 95-2314-B-075A-020-MY3
＊研究部：＊李文珍(副研究員)，＊吳承修，林赫(興大生命科學系)，李奕德(新陳代謝科)，＊吳靜玫，曾振志(婦產部)，周明明(婦產部)，許惠恒(內科部主任)。 |
3.560
論文
（8/56）
|
||
| 15 |
Sesamin mitigates inflammation and oxidative stress in endothelial cells exposed to oxidized low-density lipoprotein.Journal of Agriculture and Food Chemistry 2009, 57, 11406–11417.通過IRB認證許可書編號：C07045
TCVGH-983001C, TCVGH-HK958001, TCVGH-NCNU947904,NSC 95-2314-B-075A-020-MY3
研究部、＊院外人士：李文珍(研究部)，＊歐秀中，吳靜玫(研究部)，李奕德(新陳代謝科)，林時逸(新陳代謝科)，＊林麗雲，＊蔡昆霖，＊李信達，許惠恒(內科部主任) |
2.532
論文
（1/35）
|
||
|
II.非SCI期刊論文
|
||||
| 1 |
Pheochromocytoma presenting with normal urinary catecholamines and metabolities:
A case report.台灣內分泌暨糖尿病學會雜誌Formos J Endocrin Metab 2009;1:33-37.
*新陳代謝科：*陳盈佑（總醫師） |
病例報告
98N107 |
||
|
97年
|
||||
|
I. SCI期刊論文
|
||||
|
編號
|
題目（畫線者為通訊作者）
|
SCI IF/ Rank
|
||
|
1
|
Early Improvements in insulin sensitivity and inflammatory markers are induced by pravastatin in nondiabetic subjects with hypercholesterolemia
Clin Chim Acta 390(1-2): 49-55, 2008
*教研部、#新陳代謝科、@心臟內科、†家醫科：*李文珍（副研究員）、#許惠恒（主治醫師）、@李文領、†唐憶淨、@梁凱偉、#簡育宏
|
2.328
(論文)
(6/25)
|
||
|
2
|
High total-to-HDL cholesterol ratio predicting deterioration of ankle brachial index in Asian type 2 diabetic subjects
Diabetes research & clinical practice 79: 419-426, 2008
TCVGH-953503A；NSC 94-2314-B-075A-012
*新陳代謝科、#教研部：*李奕德 (主治醫師)，黃建寧，#李文珍，李鴻森，*許惠恒 (主治醫師)
|
1.837
(論文)
(63/93)
|
||
|
3
|
Effect of Weith Loss on Proinflammatory State of Mononuclear Cells in Obese Women
Obesity 16: 1033-1038, 2008
TCVGH-TTMHH948502；TCVGH-963001C；NSC-95-2314-B-075A-020-MY3
*新陳代謝科、#教研部、@營養室：*許惠恒 (主治醫師)，張子明，#李文珍，歐秀中，*吳靜玫，*曾立年，@郎惠芬，*吳承修，@萬居仁，*李奕德
|
3.491
(論文)
(30/93)
|
||
|
4
|
Predictors of mortality in holpitalized diabetic patients: A 7-yearn prospective study
Diabetes Research and Clinical Practice 80: 449-454, 2008
NSC 95-2314-B-075A-020-MY3；TCVGH-953505C
*藥劑部、#教研部、@新陳代謝科：*吳玫君 (藥師)，#李文珍，陳昇明，@林時逸，@李奕德，@鄭啟源，@曾立年，*劉瑛媚，*陳本源，@許惠恒 (主治醫師)
|
1.837
(論文)
(63/93)
|
||
|
5
|
Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects
Diabets research & clinical practice 81: 345-350, 2008
TCVGH-963501A
*新陳代謝科、#教研部：*李奕德（主治醫師），黃建寧，#李文珍，李鴻森，*許惠恒（主治醫師）
|
1.837
(論文)
(63/93)
|
||
|
6
|
Effect of Xylooligosaccharides in Type 2 Diabetes Mellitus
J Nutr Sci Vitaminol
*新陳代謝科：*許惠恒 (主治醫師)、詹吟菁 (院外人士)
|
0.758
(論文)
(43/55)
|
||
|
7
|
Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes
Diabetes Med
*新陳代謝科、#教研部：*李奕德 (主治醫師)、*許惠恒 (主治醫師)、#李文珍
|
2.484
(簡報型論文)
(45/93)
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
糖尿病前期與心臟血管疾病之關係及處置流程建議
J of Internal Medicine of Taiwan (內科學誌)
*新陳代謝科：*許惠恒（主治醫師）、何橈通（院外人士）
|
(綜論)
|
||
|
96年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Circulating hepatocyte growth factor level but not basic fibroblast growth factor level is elevated in angiography-proven symptomatic peripheral artery disease
Angiology 58: 420-428, 2007
*心臟內科、#新陳代謝科、@教研部：林俊彣(院外人士)，#許惠恒，@李文珍，*陳穎從，*劉尊睿，*丁紀台，*李文領（主治醫師)
|
0.943
(論文)
(44/51)
|
||
|
2
|
Benign parathyroid adenoma presenting with unusual parathyroid crisis anemia and myelofibrosi
J Formos Med Assoc 106: S13-S16, 2007
*新陳代謝科、#病理部：*黃詩旋（95年9月離職主治醫師），吳允升，#周冠，#黃姿瑜，*林時逸（主治醫師），*許惠恒
|
0.474
(病例報告)
|
||
|
3
|
The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese
Metabolism Clinical and Experimental 56: 1708-1713, 2007
TCVGH-953503A
*新陳代謝科、#教研部：*李奕德 (主治醫師)，#李文珍，黃建寧，*許惠恒（主治醫師）
|
2.294
(論文)
(44/89)
|
||
|
4
|
C-reactive protein gene polymorphism 1009A>G is associated with serum CRP levels in Chinese men: a TCVGHAGE study
Clin Chim Acta 382: 117-123, 2007
TCVGH-953506D；NSC 95-2314-075A-020-MY3
*新陳代謝科、#教研部、@心臟內科: *許惠恒（主治醫師），Chen YD，#余振源，Guo X，#李作卿，#李文珍，@陳穎從，Rotter JI.
|
2.149
(論文)
(5/23)
|
||
|
5
|
Impact of clinical characteristics of individual metabolic syndrome on the severity of insulin resistance in chinese adults
J Korean Med Sci 22: 74-80, 2007
*新陳代謝科：謝昌勳(院外人士)，洪乙仁，吳篤安，郭熙文，李建興，*許惠恒，裴馰
（院外人士）
|
0.650
(論文)
(68/105)
|
||
|
6
|
Initial Serum Glucose Level as a Prognostic Factor in the First Acute Myocardial Infarction
Ann Emerg Med 49: 618-626, 2007
*新陳代謝科：許金旺，Chen HH，*許惠恒，Chu SJ，Shen YS，吳清平，簡國龍.
|
2.782
(論文)
(2/110）
|
||
|
7
|
Genotype and Plasma concentration of Cystatin C in Patients with Late-Onset Alzheimer disease
Dement Geriatr Cogn Disord 23: 251-257,2007
TCVGH 934006B；NSC 92-2320-B-006-099
*精神部、#新陳代謝科：*卓良珍(主治醫師)，#許惠恒，白明奇，郭余民(院外人士)
|
2.603
(論文)
(38/148)
|
||
|
8
|
Positive associations of bone mineral density with body mass index, physical activity and blood triglyceride level in men over 70 years old: a TCVGHAGE study
J Bone Miner Metab 25: 54-59, 2007
TCVGH-925704D；TCVGH-935701D；TCVGH-945703D；TCVGH-955701A, NHRI-RE89P003
*家醫科、#新陳代謝科、@教研部、+心臟內科：*唐憶淨(主治醫師)，#許惠恒，*劉丕華，@李文珍，+陳穎從（主治醫師）
|
0.464
(論文)
(67/89)
|
||
|
9
|
Serum testosterone level and related metabolic factors in men over 70 years old
J. Endocrinol. Invest. 30: 451-458, 2007
TCVGH-925704D；TCVGH-935701D；TCVGH-945703D；TCVGH-955701A；NHRI-RE89P003
*家醫科、#教研部、+心臟內科、@新陳代謝科：*唐憶淨(主治醫師)，#李文珍，+陳穎從，*劉丕華，李孟智，@許惠恒（主治醫師）
|
1.496
(論文)
(65/890）
|
||
|
10
|
Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells
Archives of Toxicology 81: 421-432, 2007
NSC 94-2314-B-075A-012；TCVGH-953505C；TCVGH-TTMMH958502
*教研部、#新陳代謝科：歐秀中（院外人士），周芬碧，#許惠恒、*徐士蘭、*李文珍（副研究員）
|
1.663
(論文)
(39/75)
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
Metabolic syndrome in uremic subjects: another facet is emer
Acta Nephrologica 台灣腎臟醫學會雜誌）18: 193-194, 2007
新陳代謝科：許惠恒（主治醫師）
|
(綜論)
|
||
|
2
|
阿斯匹林在初級預防中的最佳運用-族群和劑量的選擇
J Intern Med Taiwan (內科學誌) 18: 1-10, 2007
*新陳代謝科：林中生（院外人士），*許惠恒，陳昌明，吳造中，何橈通，許重義，徐粹烈，盧玉強，陳明豐（院外人士）
|
(綜論)
|
||
|
3
|
Effect of glyburide-metformin combination tablet in patients with type 2diabetes
J Chin Med Assoc (中華醫學會雜誌) 70: 473-480, 2007
TCVGH-953505C；NSC 95-2314-B-075A-020-MY3
*新陳代謝科、#教研部、@家醫科：*簡幸嬉（離職進修住院醫師），張淳堆，祝年豐，謝勝湖，黃禹堯，*李奕德，#李文珍，@唐憶淨，*許惠恒（主治醫師）
|
(論文)
IM
|
||
|
4
|
某醫學中心教學門診師資培訓介入效果之研究
J Taiwan Hospital Association (台灣醫院協會) 40: 53-62,2007
94年衛生署補助教學門診計畫
*教研部、#新陳代謝科：*張梅芳（教學組組長），*李桂蘭，陳南松，#許惠恒（主治醫師）
|
(論文)
|
||
|
95年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
Metabolism Clinical and Experimental 55:1029-1034, 2006
Yen Tjing Ling Medical Foundation CI-93-11；TCVGH-94031D
*心臟內科、#教研部、@新陳代謝科：*李文領(主治醫師)，#李文珍，*陳穎從，*劉尊睿，*梁凱偉，*丁紀台，@許惠恒 (主治醫師)
|
2.143
(論文)
(47/87)
|
||
|
2
|
Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand
Can J Cardiol 22: 691-696, 2006
Yen Tjng Ling Medical Foundation (CI-93-11)；TCVGH 943102B
*心臟內科、@新陳代謝、#教研部：*梁凱偉（主治醫師），@許惠恒，*李文領，*劉尊睿，*丁紀台，*陳穎從，#李文珍(副研究員)
|
1.297
(論文)
(40/71)
|
||
|
3
|
Rosiglitazone inhibits endothelial proliferation and angiogenesis
Life Science 78:1520-1528, 2006
NSC 93-2314-B075A-002; TCVGH-NCNU 937904
*新陳代謝科、#教研部：*許惠恒（主治醫師），#歐秀中，周芬碧，#林宗民，楊慶華
|
2.158
(論文)
(26/71)
|
||
|
4
|
Bisphosphonates Pretreatment Ameliorates Hungry Bone Syndrome Postoperatively in Subjects with Primary Hyperparathyroidism
J Bone Miner Metab 24: 255-258, 2006
*新陳代謝科：*李奕德（主治醫師），*許惠恒（主治醫師），杜思德，郭熙文，裴馰
|
1.496
(論文)
(64/87)
|
||
|
5
|
Effects of alendronate combined with hormone replacement therapy on osteoporotic postmenopausal Chinese women
Metabolism Clinical and Experimental 55: 741-747; 2006
TCVGH-883501D； TCVGH-893507D；TCVGH-903506D
*新陳代謝科、#婦產部、@放射線部、+家醫科：*曾立年(主治醫師)，*許惠恒(主治醫師)，#何師竹，@藍灝章，+胡中傑，高嘉鴻
|
2.143
(論文)
(47/87)
|
||
|
6
|
Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen, Taiwan
Diabetes Research and Clinical Practice 74: 162-168, 2006
NSC92-2314-B-010-051； NSC93-2314-B-010-040；VGH 93-198C
*新陳代謝科、@教研部: *許惠恒（主治醫師），莊紹源，@李文珍，蔡世澤，周碧瑟，陳震寰（院外人士）
|
1.730
(論文)
(56/87)
|
||
|
7
|
Manganese modulates pro-inflammatory gene expression in activated glia
Neurochemistry International 49: 62-71, 2006
TCVGH-927321D
*教研部，#泌尿外科，@新陳代謝科：*陳春榮（副研究員），#歐宴泉，@林時逸，*廖素蘭，*陳仕昀，陳建宏
|
3.211
（論文）
(57/198)
|
||
|
8
|
Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced
cytotoxicity in endothelial cells
Clin Chim Acta 364:196-204, 2006
NSC-92-2314-B-075A-004；NSC-92-2815-C-075A-001-B；TCVGH-NCHU91P103
*教研部、#新陳代謝科：*歐秀中（藥師），周芬碧，沈惠民，林宗民，楊慶華，#許惠恒（主治醫師）
|
1.961
(論文)
(6/24)
|
||
|
9
|
Protective effects of eugenol against oxidized LDL-induced cytotoxicity and adhesion
molecule expression in endothelial cells
Food and Chemical Toxicology 44:1485-1495, 2006
NSC 93-2314-B-075A-002；TCVGH-937316D；TCVGHNCHU 91P103
*教研部、#新陳代謝科：*歐秀中（藥師），周芬碧，林宗民，楊慶華，#許惠恒（主治醫
師）
|
2.341
（論文）
(5/94)
|
||
|
10
|
Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion
molecule expression in endothelial cells
Chem Biol Interact 15:161:1-13, 2006
NSC94-2314-B-075A-012；TCVGH-953505C； TCVGH-947303A；TCVGH-HK-938003
*教研部、#新陳代謝科：*歐秀中（藥師），周芬碧，林宗民，楊慶華，#許惠恒
（主治醫師）
|
2.789
（論文）
(11/75)
|
||
|
11
|
Circulating CD40 ligand is elevated only in patients with more advanced symptomatic
peripheral arterial diseases
Thrombosis Research 118:619-626, 2006
TCVGH-933107D; Yen Tjing Ling Medical Foundation CI-93-11
*教研部、#新陳代謝科、@心臟內科：*李文珍(副研究員)，#許惠恒，@陳穎從、@劉尊睿、@梁凱偉、@丁紀台、@李文領(主治醫師)
|
1.541
（論文）
(30/51)
|
||
|
12
|
The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians
Int J Clin Pract 59: 1408-1416, 2005
*新陳代謝科：裴馰（院外人士），郭熙文，吳篤安，T-Y Lin，M-C Hseih，C-H Lee，W-L Hsu，S-P Chen，*許惠恒，J-C Li.(院外人士)
|
1.137
(論文)
(38/102)
|
||
|
13
|
Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein
Metabolism Clinical and Experimental 55: 439-444, 2006
*新陳代謝科：洪乙仁（院外人士），裴馰，郭熙文，謝晶勲，何志聰，范琦，*許惠恒
|
2.143
(論文)
(47/87)
|
||
|
14
|
Characteristics predicting dyslipidemia in drug-naive type 2 diabetes patients
J Chin Med Assoc（中華醫誌）69: 404-408, 2006
*新陳代謝科：林世鐸(院外人士)，杜思德（院外人士），許人文，林國川，*許惠恒
|
(論文)
IM
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
尿酸是否為代謝症候群之另一個組成？
Journal of Chinese Medicine Association (中華醫學會雜誌) 69: 99-100, 2006
新陳代謝科：許惠恒(主治醫師)，曾耀賢
|
(綜論)
IM
|
||
|
2
|
An emerging link between insulin resistance and inflammation
Journal of Chinese Medicine Association (中華醫學會雜誌) 69: 245-247, 2006
新陳代謝科：林時逸（主治醫師），許惠恒（主治醫師）
|
(綜論)
IM
|
||
|
94年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Different Tumor Necrosis Factor-a-Associated Leptin Expression in Rats with Dimethylnitrosamine and Bile Duct Ligation-Induced Liver Cirrhosis
Metabolism 54: 445-452, 2005
NSC 91-2314-B-075A-009;NSC 92-2314-B-075A-004; NSC 93-2314-B-075A-002; TCVGH 937303C; TCVGH 937301A
*新陳代謝科、#教研部：*林時逸（主治醫師），#陳文英，#邱雲棕，#李文珍，吳鴻昇，#許惠恒（主治醫師）
|
2.013
(論文)
(49/88)
|
||
|
2
|
Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha
Am J Physiol Endocrinol Metab 288: E493-E501, 2005.
TCVGH-927301C；NSC 92-2314-B-075A-004
*新陳代謝科、#教研部：*林時逸（主治醫師），#陳文英，李發耀，黃青真，#許惠恒（主治醫師）
|
3.828
(論文)
(17/88)
|
||
|
3
|
Stimulated resistin expression in white adipose of rats with bile duct ligation-induced liver cirrhosis: relationship to cirrhotic hyperinsulinemia and increased tumor necrosis factor-alpha
Mol Cell Endcorinol 232:1-8, 2005
TCVGH 937316D；NSC 91-2314-B-075A-009
*新陳代謝科、#教研部：*林時逸（主治醫師），#許惠恒，#陳文英，李發耀，黃青真（院外人士）
|
2.637
(論文)
(37/88)
|
||
|
4
|
Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: a randomized, double-blinded, placebo-controlled study in obese women.
Life Sciences 76: 2137-2145, 2005
NSC91-2314-B075A-009；TCVGH-927301C & TCVGH-927310D
*教研部、#營養室：*許惠恒（主治醫師），金惠民，*李文珍，#萬居仁，蘇秀悅，郎惠芬
|
1.944
(論文)
(32/72)
|
||
|
93年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Diabet Med 21: 336-341, 2004
*新陳代謝科、#教研部、@醫檢部、**心臟內科：*游慧宜，#許惠恒，@宋育民，@劉惠珍，#李文珍，**陳穎從
|
2.172
（論文）
(39/88)
|
||
|
2
|
Metabolic syndrome and its contribution to coronary artery disease in non-diabetic subjects
J Formos Med Assoc 103: 317-319, 2004
*新陳代謝科、#教研部、@心臟內科：*林榮宗，#李文珍，*鄭啟源，#許惠恒，
@陳穎從
|
0.400
（論文)
(79/107)
|
||
|
3
|
Metabolism 53: 922-926, 2004
*新陳代謝科、#家醫科、@教研部：*林時逸，#王雅瑜，@許惠恒
|
2.009
（論文）
(42/88）
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
糖尿病酮酸中毒合併嚴重低磷血症及急性呼吸衰竭J Chin Med Assoc（中華醫學會雜誌）67: 355-359, 2004
新陳代謝科：劉伯瑜，鄭啟源
|
(病例報告)
|
||
|
92年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Familial form of thyroid dysgenesis: report of thyroid hemiagenesis with accompanying graves' disease in a woman whose daughter has thyroid agenesis
Horm Res 59: 47-49, 2003
*新陳代謝科、#教研部：*李奕德，#許惠恒，*林時逸
|
1.231
(病例報告)
(61/88)
|
||
|
2
|
Relationship of stressful life events, anxiety and depression to hyperthyroidism in an asian population
Horm Res 60: 247-251, 2003
*新陳代謝科、#教研部、@精神科：*李奕德，#許惠恒，*廖翊儒，*林時逸，#李文珍，@林志堅
|
1.231
(論文)
(61/88)
|
||
|
3
|
Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancerClin Endocrinol 58:513-518, 2003
TCVGH-903503A
*新陳代謝科、#家醫科、@教研部：*林時逸，#王雅瑜，@許惠恒
|
2.674
(論文)
(31/88)
|
||
|
4
|
Metabolic effects of Growth Hormone Therapy in an Alstrom Syndrome patient
Horm Res 60: 297-301, 2003
*新陳代謝科、#教研部：戴再松，*林時逸，#許惠恒
|
1.231
(論文)
(61/88)
|
||
|
5
|
Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis
Horm Res 60:185-190, 2003
TCVGH-913503A
*家醫科、#新陳代謝科：*王雅瑜，#林時逸
|
1.231
(論文)
(61/88)
|
||
|
6
|
A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men
Clin Endocrinol 58:380-385,2003
NSC90-2314-B075A-004；VTY89-P2-14; TCVGH 903506D
*教研部，#新陳代謝科、@內科部：*許惠恒，@陳穎從，*李文珍，#王貞文，#林時逸
|
2.674
(論文)
(31/88)
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
Mood disorder and secondary adrenal insufficiency after pituitary tumor operation and radiotherapy
J Chin Med Assoc（中華醫學雜誌）66: 375-378, 2003
*新陳代謝科、#教研部：*李奕德，*林時逸，#許惠恒
|
病例報告
|
||
|
91年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis
Clinical Endocrinologh 57:805-811, 2002
*新陳代謝科、#教學研究部：*林時逸，Ya Yu Wang，#許惠恒
|
2.465
(論文)
(33/90)
|
||
|
2
|
Graves' Disease Presented as Painful Goiter
Horm Res 57:53-56, 2002
*新陳代謝科、#教學研究部：*趙振順，*林時逸，#許惠恒
|
1.122
(病例報告)
(66/90)
|
||
|
3
|
Simvastatin Reduces Plasma Concentration of High-sensitivity C-reactive Protein in Type 2 Diabetic Patients with Hyperlipidemia
Journal of Diabetes and Its Complications 16:382-385, 2002
*新陳代謝科、#教學研究部、@醫學檢驗部：*李奕德，#許惠恒，*林時逸，*李文珍，@宋育民，劉惠珍
|
0.931
(論文)
(70/90)
|
||
|
II.非SCI期刊論文
|
||||
|
1
|
Diagnosis of Thyroid Metastasis in Cancer Patients with Thyroid Mass by Fine Needle Aspiration Cytology and Ultrasonography
中華醫誌65:101-105, 2002
*新陳代謝科、#教學研究部、@病理部：*林時逸，#許惠恒，@張銘城，K-T Tang，T-I Lee，林宏達
|
論文
|
||
|
2
|
Evaluation of Secondary Adrenal Insufficiency: Findings by Corticotropin-Releasing Hormone Test and Magnetic Resonance Imaging in Parallel
中華醫誌65:156-163, 2002
*新陳代謝科：*林時逸，J G-S Won，T-I Lee，K-T Tang，林宏達
|
論文
|
||
|
3
|
應用人體生物阻抗儀分析胰島素造成快速體重增加的糖尿病病患身體組成成分-病例報告
高雄醫誌18:45-48, 2002
*新陳代謝科、#教學研究部：*李奕德，*林時逸，#許惠恒
|
病例報告
|
||
|
4
|
疑似誤用Repaglinide導致低血糖
長庚醫誌25:783-786, 2002
*新陳代謝科、#教學研究部：*李奕德，#許惠恒，*林時逸
|
病例報告
|
||
|
5
|
Thyroglossal Duct Cyst with Papillary Carcinoma
中華醫誌65:183-186, 2002
*新陳代謝科、#教學研究部@病理部：*趙振順，*林時逸，#許惠恒，@何霖
|
病例報告
|
||
|
6
|
A reappraisal of ovine corticotrophin-releasing hormone stimulation test in the differential diagnosis of Cushing’s syndrome: a comparison with the standard high-dose dexamethasone suppression test
Chinese Medical J 65: 474-482，2002
*新陳代謝科：李亭儀，*林時逸，翁錦興，鄧錦泉，葉振聲，郭清輝，林宏達
|
論文
|
||
|
90年
|
||||
|
I. SCI期刊論文
|
||||
|
1
|
Improvement in Endothelial Dysfunction with LDL Cholesterol Level <80 mg/dl in Type 2 Diabetic Patients
Diabetes Care 24:1499-1501, 2001(NSC89-2314-B075A-026)
新陳代謝科、*內科部：許惠恒，*陳穎從，李文珍
|
4.992
(論文)
|
||
|
2
|
Tumor Necrosis Factor α-238 and –308 Polymorphisms Do Not Associate with Insulin Resistance in Hypertensive Subjects
Metabolism 50:1447-1451, 2001(NSC89-2314-B075A-001)(VTY89-P2-14)(TCVGH836501C)
*新陳代謝科、#內科部：*許惠恒，*李文珍，林立元，張若麟， #陳穎從
|
1.952
(論文)
|
||
|
3
|
Simvastatin Treatment on Postprandial Hypertriglyceridemia in Type 2 Diabetes Mellitus Patients with Combined Hyperlipidemia.
Metabolism 50:355-359, 2001.(NSC89-2314-B075A-001)
*新陳代謝科、#內科部：*許惠恒，鄭啟源，*李文珍，*林時逸，裴馰，#陳穎從
|
1.952
(論文)
|
||
|
4
|
Elevated Plasma Homocysteine Concentrations Six Months after Gastroplasty in Morbidly Obese Subjects
Internal Med 40:584-588. 2001(NSC89-2314-B-075A-026)(TCVGH893501C)
新陳代謝科、*一般外科、#營養室：許惠恒，*吳鴻昇，王貞文，#萬居仁，李文珍
|
0.643
(論文)
|
||
|
5
|
Endothelial Dysfunction in Type 2 Diabetes Mellitus Subjects with Peripheral Artery Disease
Int J Cardiol 78:19-25, 2001(TCVGH883001D)(TCVGH893505A)
新陳代謝科、*心臟內科：游蕙宜，許惠恒，*賴舉仁，李文珍，* 陳穎從
|
|||
分享
首長信箱
分享
